about
Gallium maltolate treatment eradicates Pseudomonas aeruginosa infection in thermally injured miceThe transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activityGallium disrupts iron metabolism of mycobacteria residing within human macrophages.Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment OptionsInvestigations on the Ga(III) Complex of EOB-DTPA and Its 68Ga Radiolabeled Analogue.In vitro activity of gallium maltolate against Staphylococci in logarithmic, stationary, and biofilm growth phases: comparison of conventional and calorimetric susceptibility testing methodsGallium disrupts iron uptake by intracellular and extracellular Francisella strains and exhibits therapeutic efficacy in a murine pulmonary infection model.Anaplastic Thyroid Carcinoma: Current Treatments and Potential New Therapeutic Options with Emphasis on TfR1/CD71.Medical applications and toxicities of gallium compounds.Emerging applications of liquid metals featuring surface oxides.Drug repurposing as an alternative for the treatment of recalcitrant bacterial infections.The 26S proteasome complex: an attractive target for cancer therapyEvaluation of Gallium Citrate Formulations against a Multidrug-Resistant Strain of Klebsiella pneumoniae in a Murine Wound Model of Infection.Evaluation of a Novel Tc-99m Labelled Vitamin B12 Derivative for Targeting Escherichia coli and Staphylococcus aureus In Vitro and in an Experimental Foreign-Body Infection Model.In vitro and in vivo biological activities of iron chelators and gallium nitrate against Acinetobacter baumannii.Antimicrobial Activity of Gallium Protoporphyrin IX against Acinetobacter baumannii Strains Displaying Different Antibiotic Resistance Phenotypes.Iron-targeting antitumor activity of gallium compounds and novel insights into triapine(®)-metal complexes.Gallium-containing anticancer compounds.Synchrotron X-ray fluorescence microscopy of gallium in bladder tissue following gallium maltolate administration during urinary tract infectionDevelopment of a poly(ether urethane) system for the controlled release of two novel anti-biofilm agents based on gallium or zinc and its efficacy to prevent bacterial biofilm formationTargeted Delivery of Glucan Particle Encapsulated Gallium Nanoparticles Inhibits HIV Growth in Human Macrophages.Gallium-mediated siderophore quenching as an evolutionarily robust antibacterial treatment.Ga@C-dots as an antibacterial agent for the eradication of Pseudomonas aeruginosa.Metallic ions as therapeutic agents in tissue engineering scaffolds: an overview of their biological applications and strategies for new developments.Substituted hydroxyapatites with antibacterial properties.Nuclear imaging of amyloidosis.Gallium Compounds Exhibit Potential as New Therapeutic Agents against Mycobacterium abscessus.Gallium-Protoporphyrin IX Inhibits Pseudomonas aeruginosa Growth by Targeting Cytochromes.The antibacterial activity of Ga3+ is influenced by ligand complexation as well as the bacterial carbon source.Activity of Gallium Meso- and Protoporphyrin IX against Biofilms of Multidrug-Resistant Acinetobacter baumannii Isolates.Gallium-Loaded Dissolvable Microfilm Constructs that Provide Sustained Release of Ga(3+) for Management of Biofilms.68Ga-chloride PET reveals human pancreatic adenocarcinoma xenografts in rats--comparison with FDG.Identification and characterization of a novel-type ferric siderophore reductase from a gram-positive extremophile.The gallium complex KP46 exerts strong activity against primary explanted melanoma cells and induces apoptosis in melanoma cell lines.A Novel Glass Polyalkenoate Cement for Fixation and Stabilisation of the Ribcage, Post Sternotomy Surgery: An ex-Vivo Study.Copper import in Escherichia coli by the yersiniabactin metallophore system.Pyoverdine and proteases affect the response of Pseudomonas aeruginosa to gallium in human serumAn In Vitro Comparison of PMMA and Calcium Sulfate as Carriers for the Local Delivery of Gallium(III) Nitrate to Staphylococcal Infected Surgical SitesAmmonium-Chloride-Potassium Lysing Buffer Treatment of Fully Differentiated Cells Increases Cell Purity and Resulting Neotissue Functional Properties.Gallium maltolate as an alternative to macrolides for treatment of presumed Rhodococcus equi pneumonia in foals.
P2860
Q24650213-3C6D6C93-0F60-40B8-8EB1-446A290C83E8Q24683150-BFF7AD82-9D0F-4D4D-BD40-3CC4D86604E2Q28344777-CB41008D-C53B-4975-A3AF-E5CA158F20E3Q30235064-B75188ED-0214-47AF-806F-B87E1E25FF4FQ31126059-BE7BFE2E-0965-46BC-BB46-A93A62ADBDFEQ33558882-3B0B526A-551C-486D-A9C4-CD1D18679278Q33558904-8542C9C7-4EC2-4F10-AC48-EAECBCE8E585Q33914771-282F341E-72D4-478A-B19D-75E37B743C88Q33965885-D657C57D-4C76-43DC-91B3-449FE1707F3BQ34510831-08EA11EC-DFE5-48B4-8C1A-35026E172C6DQ35336154-B385AFA6-A84D-4CE8-8273-4152988EE122Q35624079-5FFE2F32-CD20-485F-802D-EF35F42E37E1Q35736631-CA98AF3C-FCE9-484A-99A4-8FFFB6079BA5Q36269747-6E271D16-C982-43DB-A65F-D330103D87EBQ36276776-FF05857B-A17D-44C2-B452-AD2ED4420CFAQ36290719-3E447D1A-3F51-4EC5-AA01-99CC1F85C177Q36568904-5B273852-C271-4E1B-B5CE-1BC961757EA3Q36616612-0DB0D2C3-38CA-4C0F-8C8A-2B5E93714510Q37263450-391C2856-8690-4B69-A8C0-96B0CD5C2B81Q37381385-CBB9B83D-E4A0-416F-B5F0-56B80BF47AFEQ37443661-ED2890FE-4358-4388-97FA-58FAEE82435AQ37604241-709104F1-023A-4FE9-8519-B696A76ADF7DQ37610456-7B52B17F-DF0B-4CB3-A99E-45E4F3A78875Q37967128-FC959F99-9967-4983-BC9E-474CAFD07C5BQ38221883-196EA58C-E94F-4610-94D7-F498BFDC849DQ38234973-2C9ABF9C-A116-4DFD-A334-30BE35F23939Q38868528-9CEA5402-D184-488E-995B-49E89A65F9C3Q38968733-81904537-20D0-4C16-A706-13E6BA2A0853Q39468168-6492FA16-76E0-4CE3-8A51-58E0AA2D4F27Q39649887-8E297A98-B8D9-435F-83B2-5D5CF9A876D7Q39657518-2DF65FEC-273E-4E1F-A676-8930536963B3Q39792434-54340935-C729-4B03-89E8-4C223206372DQ39820416-ECD70B98-6B76-46DD-9EFF-D42F830EFB26Q39827690-4BB157F2-DF59-4E7D-BF3C-205007643A6AQ39870965-A7F1C0AC-D48E-412D-BCD7-457B7EC57929Q40113297-419EF922-2A9F-4C1E-BB38-AC7955F8B953Q40762973-B6CF0D20-321E-4798-9450-EFF01652FD00Q40788328-B31B4905-2548-41D3-8122-A4484D6C3B1DQ41177487-1E4AE373-910F-4717-8364-66518D292C88Q41338773-12189791-D2A9-461F-989F-226679E381A5
P2860
description
1998 nî lūn-bûn
@nan
1998 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
name
Mechanisms of therapeutic activity for gallium
@ast
Mechanisms of therapeutic activity for gallium
@en
Mechanisms of therapeutic activity for gallium
@nl
type
label
Mechanisms of therapeutic activity for gallium
@ast
Mechanisms of therapeutic activity for gallium
@en
Mechanisms of therapeutic activity for gallium
@nl
prefLabel
Mechanisms of therapeutic activity for gallium
@ast
Mechanisms of therapeutic activity for gallium
@en
Mechanisms of therapeutic activity for gallium
@nl
P1476
Mechanisms of therapeutic activity for gallium
@en
P2093
Bernstein LR
P304
P407
P577
1998-12-01T00:00:00Z